No change
Add to watchlist
Create an alert
Stocks and Shares ISACellbxhealth PLC, formerly ANGLE plc, is a global precision circulating tumor cell (CTC) intelligence company specializing in innovative circulating tumor cell solutions for use in research, drug development and clinical oncology. The product portfolio comprises the Parsortix platform with associated consumables and assays. Its Parsortix platform harvests CTCs from blood and enables comprehensive downstream analysis - including whole-cell imaging, proteomic profiling and full genomic workflows - supporting research, drug development and clinical oncology. Its Parsortix PC1 system is the first FDA cleared medical device for the capture and harvest of intact CTCs from metastatic breast cancer (MBC) patient blood for subsequent, user-validated analysis.Its Parsortix PR1 System is a semi-automated platform for epitope-independent CTC isolation, used in research and clinical trials for multiple cancer types.
Company Information
About this company
Key people
Jan Groen
Non-Executive Independent Chairman of the Board
Peter Michael Collins
Chief Executive Officer
Ian F. Griffiths
Chief Financial Officer, Finance Director, Executive Director, Company Secretary
Klaas de Boer
Non-Executive Director
Benjamin Jacob Hart
Non-Executive Director
Kimberley Anne Oreskovic
Non-Executive Director
Click to see more
Key facts
- Shares in issue1.14bn
- EPICCLBX
- ISINGB0034330679
- LocationUnited Kingdom
- SectorTechnology
- IndustryScientific & Technical Instr.
- Market cap£18.50m
- Employees119
- ExchangeLondon Stock Exchange (LON)
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.